ProMIS Neurosciences Files 8-K

Ticker: PMN · Form: 8-K · Filed: 2025-01-27T00:00:00.000Z

Sentiment: neutral

Topics: disclosure, financials

TL;DR

ProMIS Neurosciences filed an 8-K on Jan 27, 2025, with updated disclosures.

AI Summary

ProMIS Neurosciences Inc. filed an 8-K on January 27, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as AMORFIX LIFE SCIENCES LTD, is incorporated in Ontario, Canada, and its principal executive offices are located in Toronto.

Why It Matters

This filing indicates ProMIS Neurosciences is providing updated disclosures and financial information to the SEC, which is important for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, primarily for disclosure and financial statements, without immediate significant operational or financial news.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

When was this 8-K filed?

This 8-K was filed as of January 27, 2025.

What was ProMIS Neurosciences Inc. formerly known as?

ProMIS Neurosciences Inc. was formerly known as AMORFIX LIFE SCIENCES LTD.

Where are ProMIS Neurosciences Inc.'s principal executive offices located?

ProMIS Neurosciences Inc.'s principal executive offices are located at Suite 200, 1920 Yonge Street, Toronto, Ontario, M4S 3E2.

In which jurisdiction is ProMIS Neurosciences Inc. incorporated?

ProMIS Neurosciences Inc. is incorporated in Ontario, Canada.

Filing Stats: 489 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-01-27 07:30:16

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 27, 2025, ProMIS Neurosciences Inc. posted to its website an updated corporate presentation. A copy of the corporate presentation is attached hereto as Exhibit 99.1. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation, dated January 27, 2025 104 Cover Page Interactive Data File (embedded within Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROMIS NEUROSCIENCES INC. Date: January 27, 2025 By: /s/ Neil Warma Name: Neil Warma Title: Chief Executive Officer

View on Read The Filing